Abstract
Asymptomatic uropathogenic Escherichia coli (UPECs) are the leading cause of asymptomatic bacteriuria (ABU) in humans. So this study aimed to identify and characterize ABU UPECs from hospitalized patients of Kolkata, India, with respect to their antibiogram profile, phylogeny, pathogenicity islands, and virulence factor gene acquisition and FimH mutations in comparison to symptomatic UPECs. E. coli was detected biochemically in 44.44% (20/45) and 32.26% (20/62) of urine culture-positive asymptomatic and symptomatic hospitalized individuals respectively. Ninety-five percent of the asymptomatic isolates were multidrug resistant (MDR) compared to the symptomatic isolates (100%). Significant predominance of unknown phylogroup, pathogenicity island markers (PAI IV536, PAI I CFT073), and distribution patterns of different virulence factor genes respectively was evident among both groups. A significant correlation was observed between both groups of isolates with respect to their antibiotic resistances (except imipenem, amikacin, and nitrofurantoin), prevalence of phylogenetic groups and PAIs, and virulence factor gene (fimH, papC, papEF, papGII, iucD, and cnf1) acquisition. Pathoadaptive FimH adhesin mutations, especially hot spot mutation V27A, were detected in 80% asymptomatic isolates mostly reported in symptomatic ones worldwide. Moreover, this is the first study from India that reported incidence of “Unknown” phylogroup, pathogenicity island markers, and potentially pathoadaptive FimH mutations in asymptomatic UPECs isolated from hospitalized patients which further indicated that these ABU E. coli might have originated from their symptomatic counterparts due to unbridled use of unprescribed antibiotics. Therefore, this study demands antibiotic de-escalation along with regular and intricate monitoring at the molecular level for efficient management of ABU that addresses a major public health concern.
Similar content being viewed by others
References
Abbo LM, Hooton TM (2014) Antimicrobial stewardship and urinary tract infections. Antibiotics 3:174–192
Basu S, Mukherjee SK, Hazra A, Mukherjee M (2013) Molecular characterization of uropathogenic Escherichia coli: nalidixic acid and ciprofloxacin resistance, virulent factors and phylogenetic background. J Clin Diagn Res 7:2727–2731
Bien J, Sokolova O, Bozko P (2012) Role of uropathogenic Escherichia coli virulence factors in development of urinary tract infection and kidney damage. Int J Nephrol 2012:681473–681487
Clermont O, Christenson JK, Denamur E, Gordon DM (2013) Rapid and simple determination of the Escherichia coli phylogenetic group. Environ Microbiol Rep 5:58–65
CLSI (2018) Performance standards for antimicrobial susceptibility testing: 28th informational supplement. M100- S28. Clinical and Laboratory Standards Institute, Wayne
Cope M, Cevallos ME, Cadle RM, Darouiche RO, Musher DM, Trautner BW (2009) Inappropriate treatment of catheter-associated asymptomatic bacteriuria in a tertiary care hospital. Clin Infect Dis 48:1182–1188
Dreux N, Denizot J, Martinez-Medina M, Mellmann A, Billig M, Kisiela D et al (2013) Point mutations in FimH adhesin of Crohn’s disease-associated adherent-invasive Escherichia coli enhance intestinal inflammatory response. PLoS Pathog 9:1003141–1003157
Elzayat MA, Barnett-Vanes A, Dabour MF, Cheng F (2017) Prevalence of undiagnosed asymptomatic bacteriuria and associated risk factors during pregnancy: a cross-sectional study at two tertiary centres in Cairo, Egypt. BMJ Open 7:013198–013204
Hommais F, Gouriou S, Amorin C, Bui H, Rahimy MC, Picard B et al (2003) The FimH A27V mutation is pathoadaptive for urovirulence in Escherichia coli B2 phylogenetic group isolates. Infect Immun 71:3619–3622
Iebba V, Conte MP, Lepanto MS, Di Nardo G, Santangelo F, Aloi M et al (2012) Microevolution in fimH gene of mucosa-associated Escherichia coli strains isolated from pediatric patients with inflammatory bowel disease. Infect Immun 80:1408–1417
Iranpour D, Hassanpour M, Ansari H, Tajbakhsh S, Khamisipour G, Najafi A (2015) Phylogenetic groups of Escherichia coli strains from patients with urinary tract infection in Iran based on the new Clermont phylotyping method. Biomed Res Int 2015:846219–846225
Kawamura-Sato K, Yoshida R, Shibayama K, Ohta M (2010) Virulence genes, quinolone and fluoroquinolone resistance, and phylogenetic background of uropathogenic Escherichia coli strains isolated in Japan. Jpn J Infect Dis 63:113–115
Khawcharoenporn T, Vasoo S, Ward E, Singh K (2011) Abnormal urinalysis finding triggered antibiotic prescription for asymptomatic bacteriuria in the ED. Am J Emerg Med 29:828–830
Kryger J, Burleigh A, Christensen M, Hopkins W (2015) Genetic evaluation of E. coli strains isolated from asymptomatic children with neurogenic bladders. Int J Chronic Dis 2015:206570–206574
Lee S, Yu JK, Park K, Oh EJ, Kim SY, Park YJ (2010) Phylogenetic groups and virulence factors in pathogenic and commensal strains of Escherichia coli and their association with blaCTX-M. Ann Clin Lab Sci 40:361–367
Lutay N, Ambite I, Gronberg Hernandez J, Rydstrom G, Ragnarsdottir B, Puthia M et al (2013) Bacterial control of host gene expression through RNA polymerase II. J Clin Invest 123:2366–2379
Mabbett AN, Ulett GC, Watts RE, Tree JJ, Totsika M, Ong CL et al (2009) Virulence properties of asymptomatic bacteriuria Escherichia coli. Int J Med Microbiol 299:53–63
Mukherjee M, Koley S, Mukherjee S, Basu S, Ghosh B, Chakraborty S (2015) Phylogenetic background of E. coli isolated from asymptomatic pregnant women from Kolkata, India. J Infect Dev Ctries 9:720–724
Naderi G, Haghi F, Zeighami H, Hemati F, Masoumian N (2016) Distribution of pathogenicity island (PAI) markers and phylogenetic groups in diarrheagenic and commensal Escherichia coli from young children. Gastroenterol Hepatol Bed Bench 9:316–324
Najafi A, Hasanpour M, Askary A, Aziemzadeh M, Najmeh Hashemi N (2017) Distribution of pathogenicity island markers and virulence factors in new phylogenetic groups of uropathogenic Escherichia coli isolates. Folia Microbiol 63:335–343
Phillips CD, Adepoju O, Stone N, Moudouni DK, Nwaiwu O, Zhao H et al (2012) Asymptomatic bacteriuria, antibiotic use, and suspected urinary tract infections in four nursing homes. BMC Geriatr 12:73–80
Roos V, Nielsen EM, Klemm P (2006) Asymptomatic bacteriuria Escherichia coli strains: adhesins, growth and competition. FEMS Microbiol Lett 262:22–30
Sabaté M, Moreno E, Pérez T, Andreu A, Prats G (2006) Pathogenicity island markers in commensal and uropathogenic Escherichia coli isolates. Clin Microbiol Infect 12:880–886
Samei A, Haghi F, Zeighami H (2015) Distribution of pathogenicity island markers in commensal and uropathogenic Escherichia coli isolates. Folia Microbiol 61:261–268
Srivastava R, Srivastava S, Agarwal J, Mishra B (2016) Virulence versus fitness determinants in Escherichia coli isolated from asymptomatic bacteriuria in healthy nonpregnant women. Indian J Med Microbiol 34:46–51
Tiba MR, Yano T, Leite DS (2008) Genotypic characterization of virulence factors in Escherichia coli strains from patients with cystitis. Rev Inst Med Trop Sao Paulo 50:255–260
Venkatesan KD, Chander S, Loganathan K, Victor K (2017) Study on asymptomatic bacteriuria in diabetic patients. Int J Contemp Med Res 4:480–483
Zdziarski J, Svanborg C, Wullt B, Hacker J, Dobrindt U (2008) Molecular basis of commensalism in the urinary tract: low virulence or virulence attenuation? Infect Immun 76:695–703
Acknowledgements
The authors would like to express their gratitude to Professor Nandita Basu, Director and Professor Bibhuti Saha, Head, Department of Tropical Medicine, School of Tropical Medicine, Kolkata West Bengal, India, for their kind support.
Funding
Consumable support was provided from extramural grant: Department of Science and Technology, Government of West Bengal, India (Grant No. 757 (Sanc.)/ST/P/S&T/12G-21/2014 dated 27.11.14). The work was also supported by INSPIRE fellowship grant from Department of Science &Technology, New Delhi, Government of India (No.-DST/INSPIRE Fellowship/2016/ IF160069 dated November 7, 2016).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical approval
The present study was approved by the Clinical Research Ethics Committee, School of Tropical Medicine, Kolkata (CREC-STM), Ref no. CREC-STM/317 dated 29/3/16, and informed consent was obtained from all patients for being included in this study.
Competing interests
The authors declare that they have no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
ESM 1
(DOCX 43 kb)
Rights and permissions
About this article
Cite this article
Ghosh, A., Mukherjee, M. Incidence of multidrug resistance, pathogenicity island markers, and pathoadaptive FimH mutations in uropathogenic Escherichia coli isolated from asymptomatic hospitalized patients. Folia Microbiol 64, 587–600 (2019). https://doi.org/10.1007/s12223-019-00685-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12223-019-00685-4